Thursday, October 25, 2012
The launch of the Shanghai Institute for Advanced Immunochemical Studies marks
China's first attempt to establish a center of antibody research on par with
research centers in the U.S. and Europe. Although details are still sparse, the
institute will identify targets and develop antibodies to treat cancer as well
as infectious, autoimmune and metabolic diseases.
Fulmer, T. SciBX 5(42); doi:10.1038/scibx.2012.1101
Published online Oct. 25, 2012
1. Koenig, R. HHMI
Bulletin 23(1), 25-29 (2010)
2. Schaeffer, S. BioCentury
18(50), A1-A4; Nov. 15, 2010
AND INSTITUTIONS MENTIONED
Chinese Academy of Sciences, Beijing, China
Duke University, Durham, N.C.
Fudan University, Shanghai, China
Howard Hughes Medical Institute, Chevy Chase, Md.
Institute of Developmental Biology and Molecular Medicine, Shanghai, China
National Institute of Biological Sciences, Beijing, China
The Scripps Research Institute, La Jolla, Calif.
Shanghai Advanced Research Institute, Shanghai, China
Shanghai Institute for Advanced Immunochemical Studies, Shanghai, China
University of Colorado at Boulder, Boulder, Colo.
University of Shanghai for Science and Technology, Shanghai, China
The University of Texas Southwestern Medical Center, Dallas, Texas
Yale School of Medicine, New Haven, Conn.